• Mashup Score: 10

    Author links open overlay panel C. Noel Bairey Merz MD, Martha Gulati MD, Janet Wei MD This research was supported by the National Heart, Lung, and Blood Institute under grant numbers N01HV68161, N01HV68162, N01HV68163, N01HV68164, U01HL64829, U01HL64914, U01HL64924, R01HL090957, R01HL33610, R01HL056921, R01HL146158, R03AG032631, U54AG065141, M01RR000425, UL1TR000124, UL1TR000064, and UL1TR001427. This work was also supported by the Barbra Streisand Women’s Cardiovascular Research and Education Program,

    Tweet Tweets with this article
    • Terrific paper followed by our editorial “Understanding T2MI: Thank Goodness for the Women” By Dr. Bairey Merz, @JanetWeiMD & myself @SmidtHeart @CedarsSinaiMed Diagnostic uncertainty begets therapeutic uncertainty. We await WARRIOR results! #INOCA https://t.co/XiIgxRYIPi https://t.co/aJsujF2GmH https://t.co/677E7W7yje

  • Mashup Score: 8

    Women with obstructive coronary artery disease (CAD) have a relatively lower quality of life (QoL) compared to men, but our understanding of sex differences in QoL in ischemia with no obstructive coronary artery disease (INOCA) is limited. We conducted a survey of patient members of INOCA International with an assessment of self-reported health measures. Functional capacity was retrospectively estimated using the Duke Activity Status Index (DASI), assessing levels of activities performed before and after INOCA symptom onset. Of the 1579 patient members, the overall survey completion rate was 21%. Women represented 91% of the respondents. Estimated functional capacity, expressed as metabolic equivalents (METs), was higher before compared to after INOCA diagnosis comparably for both women and men. For every one MET decline in functional capacity, there was a significantly greater decline in QoL for men compared with women in physical health (4.0 ± 1.1 vs. 2.9 ± 0.3 days/month, p < 0.001)

    Tweet Tweets with this article
    • Proud of my fellow @SRanasingheMD on her paper on sex differences in functional capacity decline in patients with #INOCA ♥️ despite similar dx, comorbidities, & symptoms, functional capacity ⤵️ assoc w/ greater adverse impact on QoL in men🆚women w INOCA https://t.co/3pym07sEdy https://t.co/Orw9zWiyku

  • Mashup Score: 12

    In this exclusive interview, DocWire News partner Dr. Hady Lichaa s peaks with Dr. Hayder Hashim about coronary microvascular dysfunction (CMD), heart disease that impacts the walls and inner lining of tiny coronary artery blood vessels. Dr. Hashim, who is an interventional cardiologist with MedStar Heart & Vascular Institute at MedStar Washington Hospital Center, provides background on the disease, summarizes the importance of microvascular assessment, describes the best way to manage CMD, and much

    Tweet Tweets with this article
    • @HadyLichaaMD speaks with Dr. Hayder Hashim about coronary microvascular dysfunction. #CMD #interventionalcardiology https://t.co/zVIrnbaewX https://t.co/oYpb3HzG37

    • Quick summary of #CMD #Coronary #MicroVascularDysfunction by the brilliant Dr @HashimHayder #INOCA: What, Why, Whom & How? https://t.co/JvikPgjeMv @ChangeAtHeart @RSohnMD @PCRonline @mirvatalasnag @mmamas1973 @hvanspall @samitshahmd @timir_paul @rdeibs @InocaInternati1 https://t.co/lzdu8DRvLK

  • Mashup Score: 12

    Alaide Chieffo sits down with Mamas Mamas to describe the clinical population, and the need for better diagnostics and treatment.

    Tweet Tweets with this article
    • My interview with @mmamas1973 on @TCTMD on #INOCA ⭐️what do we mean for #INOCA ⭐️how can we make diagnosis in #cathlab ⭐️which are the endotypes ⭐️how can we treat ⭐️on going INOCA IT Registry Beyond the Data: Understanding INOCA https://t.co/OskNP9e3vP